← Older posts Newer posts →

Generating large profits and using sometimes dubious ethics, the pharmaceutical company are an easy target for writers. However, a recent book by James le Fanu “The Rise and Fall of Modern Medicine” (see this article in the Daily Telegraph, in … Continue reading

Talk of the cost of drugs is another interesting topic.  It is a question which also involves a certain amount of philosophy.  Namely, should a prescriber solely consider clinical issues when selecting a drug or should the cost of preparations … Continue reading

About ten years ago, the medical world was startled when a paper appeared proposing the combining of several medications in a so-called “polypill” to prevent cardiovascular disease.  The medications were aspirin, statin, ACE inhibitor and a diuretic. Initially, some people … Continue reading

At last, we have clear guidance from the European Medicines Agency on the use of pioglitazone in people with diabetes in light of the new evidence of an association with bladder cancer.  They conclude that there may still be benefits … Continue reading

Generally speaking, it is always preferable to opt for the fewest possible doses of a long-term medication a day.  Adherence is improved. So the introduction by Novartis of a new once a day long-acting beta-adrenoceptor agonist for people with chronic … Continue reading

A recent article about a possible new lipid-modifying drug has raised several important issues.  Here are some of the relevant remarks from an article in the Daily Telegraph: “early trials of (the) drug, called torcetrapib, showed that, when given in … Continue reading

A relatively new drug called ranibizumab (Lucentis) can cause an improvement in diabetic macular œdema when it is injected into the eye.  According to this article, the National Institute for Health and Clinical Excellence (NICE) has just recommended that NHS … Continue reading

Drugs are having a bad time this year.  The latest batch to come under the hammer are Non-Steroidal Anti-inflammatory Drugs (NSAID) in general and Ibuprofen in particular.   An observational trial has revealed a higher incidence of atrial fibrillation in people … Continue reading

Here is the final bulletin from Linda Goldie at the ADA. On the last full day I went to a series of lectures called ‘Is there a Gold Standard for the Diagnosis of Diabetes’. As you are aware the ADA … Continue reading

In a meta-analytical study in the Journal of the American Medical Association (Priess D et al 2011) and reported in today’s Daily Telegraph, the authors find that for every 500 people taking high-dose statins, one extra person develops diabetes. However, … Continue reading

← Older posts Newer posts →
Page 3 of 41234